4//SEC Filing
Amman Bradford K. 4
Accession 0001493152-22-005660
CIK 0001716166other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:50 PM ET
Size
5.5 KB
Accession
0001493152-22-005660
Insider Transaction Report
Form 4
Amman Bradford K.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-25$3.27/sh+50,000$163,500→ 50,000 totalExercise: $3.27Exp: 2027-02-25→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]50,000 stock options granted on February 25, 2022. One-fifth vested immediately and one-fifth vests annually on each anniversary date through February 25, 2026.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001425339
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:50 PM ET
- Size
- 5.5 KB